SRF Limited (NSE:SRF)
India · Delayed Price · Currency is INR | Market Cap | 781.79B -11.2% |
| Revenue (ttm) | 157.87B +7.4% |
| Net Income | 18.35B +46.7% |
| EPS | 61.91 +46.7% |
| Shares Out | n/a |
| PE Ratio | 42.60 |
| Forward PE | 34.97 |
| Dividend | 9.00 (0.34%) |
| Ex-Dividend Date | Jan 27, 2026 |
| Volume | 521,179 |
| Average Volume | 611,330 |
| Open | 2,661.90 |
| Previous Close | 2,620.40 |
| Day's Range | 2,630.10 - 2,688.00 |
| 52-Week Range | 2,355.00 - 3,325.00 |
| Beta | 0.02 |
| RSI | 51.86 |
| Earnings Date | May 5, 2026 |
About SRF Limited
SRF Limited manufactures, purchases, and sells technical textiles, chemicals, packaging films, and other polymers. It operates through Technical Textiles Business, Chemicals Business, Performance Films and Foil Business, and Others segments. The company offers polyester and nylon tyre cord, belting, coated, and laminated fabrics; and industrial and polyester industrial yarns. It also provides fluorochemicals, such as refrigerants for room air-conditioner, automobile air-conditioner, refrigerator, and chillers under the FLORON brand; pharma prop... [Read more]
Financial Performance
In fiscal year 2026, SRF Limited's revenue was 157.87 billion, an increase of 7.44% compared to the previous year's 146.93 billion. Earnings were 18.35 billion, an increase of 46.72%.
Financial StatementsNews
Q4 2026 SRF Ltd Earnings Call Transcript
Q4 2026 SRF Ltd Earnings Call Transcript
SRF Limited Transcript: Q4 25/26
FY 2026 saw 7% revenue growth and 47% PAT increase, driven by strong chemicals and films performance despite global volatility. Strategic investments, capacity expansions, and robust R&D underpin a 15%-20% growth outlook for FY 2027.
SRF Limited Quarterly report: Q4 2026
SRF Limited has published its Q4 2026 quarterly earnings report on May 6, 2026.
SRF Limited Slides: Q4 2026
SRF Limited has posted slides in relation to its Q4 2026 quarterly earnings report, which was published on May 6, 2026.
SRF Limited Transcript: Q4 25/26
FY 2026 delivered strong growth with revenue up 7%, EBIT up 29%, and PAT up 47% year-over-year, driven by robust performance in chemicals and resilience amid global disruptions. Outlook for FY 2027 targets 15%-20% growth in chemicals, with major CapEx and new product launches planned.
SRF Limited Quarterly report: Q4 2026
SRF Limited has published its Q4 2026 quarterly earnings report on May 6, 2026.
SRF Limited Slides: Q4 2026
SRF Limited has posted slides in relation to its Q4 2026 quarterly earnings report, which was published on May 6, 2026.
SRF share price jumps over 3% as Q4 revenue rises 7% YoY to Rs 4,615 crore, net profit up 10.6%
Shares of SRF Limited surged more than 3% in morning trade on Wednesday after the company reported a healthy set of earnings for the fourth quarter of FY26, supported by…
UBS slashes SRF target to ₹2,300 and cuts earnings by 13% — here’s what’s going wrong for the chemicals giant
Global brokerage UBS maintained its Sell rating on SRF Limited while cutting its target price to ₹2,300 from ₹2,400, and slashing earnings per share estimates by 11–13% — a significant…
Why are SRF shares down 4% and Kama Holdings shares up 6% today? Explained
Shares of SRF Limited slipped nearly 4% in Tuesday’s trade after its promoter, Kama Holdings Limited, announced plans to sell...
Why are SRF shares down over 4% today? Explained
Shares of SRF Ltd fell nearly 4% on Wednesday, January 21, even after the company reported a strong set of...
SRF Ltd (BOM:503806) Q3 2026 Earnings Call Highlights: Strong Growth in Chemicals Business ...
SRF Ltd (BOM:503806) Q3 2026 Earnings Call Highlights: Strong Growth in Chemicals Business Amidst Competitive Pressures
Q3 2026 SRF Ltd Earnings Call Transcript
Q3 2026 SRF Ltd Earnings Call Transcript
SRF Limited Transcript: Q3 25/26
Revenue grew 6% year-over-year with EBIT up 23% and net profit up 60%, led by strong chemicals performance and operational efficiencies. Specialty chemicals faced pricing pressure, but a robust pipeline and new investments in pharma and next-gen gases support a positive outlook.
SRF Limited Quarterly report: Q3 2026
SRF Limited has published its Q3 2026 quarterly earnings report on January 20, 2026.
SRF Limited Slides: Q3 2026
SRF Limited has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on January 20, 2026.
SRF Limited Transcript: Q3 25/26
Revenue grew 6% year-over-year with EBIT up 23% and net profit up 60%, led by strong chemicals performance and operational efficiencies. Specialty chemicals faced pricing pressure, but a robust pipeline and new investments in pharma and next-gen gases support a positive outlook.
SRF Limited Quarterly report: Q3 2026
SRF Limited has published its Q3 2026 quarterly earnings report on January 20, 2026.
SRF Limited Slides: Q3 2026
SRF Limited has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on January 20, 2026.
SRF Ltd (NSE:SRF) Q3 2026 Earnings Report Preview: What to Look For
SRF Ltd (NSE:SRF) Q3 2026 Earnings Report Preview: What to Look For
SRF Ltd (BOM:503806) Q2 2026 Earnings Call Highlights: Strong Financial Performance Amid Market ...
SRF Ltd (BOM:503806) Q2 2026 Earnings Call Highlights: Strong Financial Performance Amid Market Challenges
SRF Limited Transcript: Q2 25/26
Q2 FY26 saw 6% revenue and 56% EBIT growth, led by strong chemicals and refrigerants performance, with robust new product launches and a strategic Chemours partnership. CapEx for FY26 is set at INR 2,200–2,300 crore, and the company expects to surpass 20% full-year chemicals growth.
SRF Limited Quarterly report: Q2 2026
SRF Limited has published its Q2 2026 quarterly earnings report on October 28, 2025.
SRF Limited Slides: Q2 2026
SRF Limited has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on October 28, 2025.
SRF Limited Transcript: Q2 25/26
Q2 FY26 saw 6% revenue and 56% EBIT growth, led by strong chemicals and refrigerants performance, with robust new product launches and a strategic Chemours partnership. CapEx for FY26 is set at INR 2,200–2,300 crore, and the company expects to surpass 20% full-year chemicals growth.